You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DREAMM 9

Showing 1 - 25 of 5,594
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin frozen liquid, Belantamab mafodotin lyophilized powder)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Belantamab mafodotin frozen liquid
  • Belantamab mafodotin lyophilized powder
  • New Haven, Connecticut
  • +58 more
Jul 27, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin)

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • New Port Richey, Florida
  • +94 more
Nov 30, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Daratumumab, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Yuma, Arizona
  • +150 more
Dec 9, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Tucson, Arizona
  • +131 more
Jul 1, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Bortezomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Yuma, Arizona
  • +34 more
Jul 22, 2022

Multiple Myeloma Trial in New Haven (Elotuzumab, Belantamab mafodotin)

Recruiting
  • Multiple Myeloma
  • New Haven, Connecticut
    Yale New Haven Hospital
Aug 15, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pom/dex (Pomalidomide plus low dose Dexamethasone))

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • Pom/dex (Pomalidomide plus low dose Dexamethasone)
  • Tucson, Arizona
  • +163 more
Feb 25, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Birmingham, Alabama
  • +25 more
Dec 9, 2022

Relapsed/Refractory Multiple Myeloma Trial in United States (Belantamab mafodotin)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Belantamab mafodotin
  • Clayton, North Carolina
  • +4 more
May 16, 2023

Gerontechnology Evaluation Framework: Outcome Validation

Not yet recruiting
  • Technology
  • Doing questionnaire
  • Hong Kong, Hong Kong
    The University of Hong Kong
Nov 24, 2023

Human Papillomavirus Infection Trial in Kunming (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

Active, not recruiting
  • Human Papillomavirus Infection
  • Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
  • GARDASIL® 9
  • Kunming, Yunnan, China
    Yunnan Center for Disease Prevention and Control
Dec 23, 2022

Immunosuppressants to Postoperative Infection and Death

Recruiting
  • Organ Transplantation
  • +2 more
  • Immunosuppressive Agents
  • Taichung, Taiwan
    Chung Shan Medical University
Nov 6, 2023

Human Papillomavirus-Related Carcinoma Trial in Austria, United States (procedure, biological, other)

Not yet recruiting
  • Human Papillomavirus-Related Carcinoma
  • Biospecimen Collection
  • +4 more
  • Birmingham, Alabama
  • +4 more
Aug 9, 2023

Hypoxia-induced Autophagy in the Pathogenesis of MAP

Not yet recruiting
  • Hypoxia
  • +3 more
  • HIF 1α and LC3B expression and MMP-9 level
  • (no location specified)
Apr 5, 2023

Diffuse Large B Cell Lymphoma Trial (anti-CD19 CAR NK cells)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • anti-CD19 CAR NK cells
  • (no location specified)
Dec 21, 2022

Pancreatic Cancer Using CA19-9 and Fecal Elastase

Active, not recruiting
  • Paancreatic Cancer
    • Seoul, Korea, Republic of
      Gangnam Severance Hospital
    Jun 27, 2023

    Cervical Cancer, Genital Wart, CIN Trial in Nanning (Zerun HPV-9, GARDASIL ®9)

    Active, not recruiting
    • Cervical Cancer
    • +4 more
    • Zerun HPV-9
    • GARDASIL ®9
    • Nanning, Guangxi, China
      GuangXi Center for Diseases Control and Prevention
    Oct 26, 2022

    Retinitis Pigmentosa Trial in Tel Hashomer (Alga Dunaliella Bardawil, Placebo (starch))

    Active, not recruiting
    • Retinitis Pigmentosa
    • Alga Dunaliella Bardawil
    • Placebo (starch)
    • Tel Hashomer, Israel
      Sheba Medical Center
    Jan 15, 2023

    Pancreatic Adenocarcinoma Trial (mFOLFIRINOX plus radiotherapy)

    Not yet recruiting
    • Pancreatic Adenocarcinoma
    • mFOLFIRINOX plus radiotherapy
    • (no location specified)
    Nov 21, 2023

    Medication Use Among American Indians Adults

    Withdrawn
    • Type 2 Diabetes
    • Medication Adherence
      • (no location specified)
      Sep 29, 2023

      Postpartum Depression Trial in New York (Engage & Connect)

      Recruiting
      • Postpartum Depression
      • Engage & Connect
      • New York, New York
        Weill Cornell Medicine
      Nov 7, 2022

      Post-traumatic Stress Disorder, Cocaine Use Disorder Trial in Zürich (Imagery, Minocycline, Placebo)

      Recruiting
      • Post-traumatic Stress Disorder
      • Cocaine Use Disorder
      • Imagery
      • +2 more
      • Zürich, Switzerland
        Psychiatric University Hospital Zurich, University of Zurich
      Jun 5, 2023

      Relapsed/Refractory Multiple Myeloma Trial in Baltimore (Belantamab Mafodotin, Cyclophosphamide and Dexamethasone)

      Recruiting
      • Relapsed/Refractory Multiple Myeloma
      • Belantamab Mafodotin, Cyclophosphamide and Dexamethasone
      • Baltimore, Maryland
        University of Maryland
      Jan 24, 2022

      MDD Trial in Providence (EMA Monitoring, Scheduling Maintenance TMS sessions)

      Recruiting
      • Major Depressive Disorder
      • EMA Monitoring
      • Scheduling Maintenance TMS sessions
      • Providence, Rhode Island
        Butler Hospital
      Nov 28, 2023

      HIV Trial (Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA), Cabotegravir (CAB-LA), Tenofovir

      Not yet recruiting
      • HIV
      • Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA)
      • Cabotegravir (CAB-LA), Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC)
      • (no location specified)
      Nov 13, 2023